Evidence map›Paper›PMID 32502416›Full record

ArticleCurrent biology : CB2020

Tyrosine Phosphorylation of the Myosin Regulatory Light Chain Controls Non-muscle Myosin II Assembly and Function in Migrating Cells.

Rocío Aguilar-Cuenca, Clara Llorente-González, Jessica R Chapman, Vanessa C Talayero, Marina Garrido-Casado, Cristina Delgado-Arévalo, María Millán-Salanova, Jeffrey Shabanowitz, Donald F Hunt, James R Sellers and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Current biology : CB, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Myosin 2 - A general contractor for the cytoskeleton.Current opinion in cell biology · 2025
    Review
  8. Article
  9. Review
  10. Non-Muscle Myosin II A: Friend or Foe in Cancer?International journal of molecular sciences · 2024
    Review
  11. Structure, regulation, and mechanisms of nonmuscle myosin-2.Cellular and molecular life sciences : CMLS · 2024
    Review
  12. Article
  13. Article
  14. International journal of molecular sciences · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Research progress in myosin light chain 9 in malignant tumors.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2021
    Article
  19. Review
  20. Filament evanescence of myosin II and smooth muscle function.The Journal of general physiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Rocío Aguilar-CuencaInstituto de Investigación Sanitaria-Hospital Universitario de la Princesa, 28006 Madrid, Spain; Universidad Autónoma de Madrid School of Medicine, 28006 Madrid, Spain.
Clara Llorente-GonzálezMolecular Mechanisms Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)-University of Salamanca, 37007 Salamanca, Spain.
Jessica R ChapmanDepartment of Chemistry, University of Virginia, Charlottesville, VA 22903, USA.
Vanessa C TalayeroMolecular Mechanisms Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)-University of Salamanca, 37007 Salamanca, Spain.
Marina Garrido-CasadoMolecular Mechanisms Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)-University of Salamanca, 37007 Salamanca, Spain.
Cristina Delgado-ArévaloInstituto de Investigación Sanitaria-Hospital Universitario de la Princesa, 28006 Madrid, Spain; Universidad Autónoma de Madrid School of Medicine, 28006 Madrid, Spain.
María Millán-SalanovaMolecular Mechanisms Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)-University of Salamanca, 37007 Salamanca, Spain.
Jeffrey ShabanowitzDepartment of Chemistry, University of Virginia, Charlottesville, VA 22903, USA.
Donald F HuntDepartment of Pathology, University of Virginia, Charlottesville, VA 22903, USA; Department of Chemistry, University of Virginia, Charlottesville, VA 22903, USA.
James R SellersCell Biology and Developmental Biology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Sarah M HeisslerDepartment of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
Miguel Vicente-ManzanaresMolecular Mechanisms Program, Centro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC)-University of Salamanca, 37007 Salamanca, Spain. Electronic address: miguel.vicente@csic.es.
Consejo Superior de Investigaciones Científicas · ESUniversity of Virginia · USHospital Universitario de La Princesa · ESNational Institutes of Health · USThe Ohio State University Wexner Medical Center · US

Funding

PROTEIN SEQUENCING BY TANDEM MASS SPECTROMETRYR01GM037537 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI HUNT, DONALD F · 1987 to 2023
$17.8M
Regulation Of Smooth and Nonmuscle MyosinZIAHL001786 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI SELLERS, JAMES · 2009 to 2025
$17.4M
Consequences of myosin-1G dimerization on its regulated interaction with actinK22HL131869 · NHLBI · OHIO STATE UNIVERSITY · PI HEISSLER, SARAH · 2018 to 2020
$727k
ROLE OF PHOSPHORYLATION AS A REGULATORY MECHANISM IN MUSCLE CONTRACTIONZ01HL001786 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI SELLERS, JAMES R. · 1985 to 2008
$601k
Intramural NIH HHS Z01 HL001786Intramural NIH HHS ZIA HL001786NHLBI NIH HHS K22 HL131869NIGMS NIH HHS R01 GM037537
6 · The paper itself

Abstract

Active non-muscle myosin II (NMII) enables migratory cell polarization and controls dynamic cellular processes, such as focal adhesion formation and turnover and cell division. Filament assembly and force generation depend on NMII activation through the phosphorylation of Ser19 of the regulatory light chain (RLC). Here, we identify amino acid Tyr (Y) 155 of the RLC as a novel regulatory site that spatially controls NMII function. We show that Y155 is phosphorylated in vitro by the Tyr kinase domain of epidermal growth factor (EGF) receptor. In cells, phosphorylation of Y155, or its phospho-mimetic mutation (Glu), prevents the interaction of RLC with the myosin heavy chain (MHCII) to form functional NMII units. Conversely, Y155 mutation to a structurally similar but non-phosphorylatable amino acid (Phe) restores the more dynamic cellular functions of NMII, such as myosin filament formation and nascent adhesion assembly, but not those requiring stable actomyosin bundles, e.g., focal adhesion elongation or migratory front-back polarization. In live cells, phospho-Y155 RLC is prominently featured in protrusions, where it prevents NMII assembly. Our data indicate that Y155 phosphorylation constitutes a novel regulatory mechanism that contributes to the compartmentalization of NMII assembly and function in live cells.

Indexed as

A549 CellsAnimalsCell MovementCHO CellsCricetulusHEK293 CellsHumansMyosin Light ChainsMyosin Type IIPhosphorylationSf9 CellsSpodopteraTyrosineMyosin Light ChainsMyosin Type IITyrosineactincytoskeletonmigrationmyosinphosphorylationtyrosine

Identifiers

PMID32502416
PMCPMC7343590
OpenAlexW3033485736

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.